These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33031836)

  • 1. Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms.
    Malaviya R; Kipen HM; Businaro R; Laskin JD; Laskin DL
    Toxicol Appl Pharmacol; 2020 Dec; 409():115272. PubMed ID: 33031836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants.
    Laskin DL; Malaviya R; Laskin JD
    Toxicol Sci; 2019 Apr; 168(2):287-301. PubMed ID: 30590802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis.
    Addis-Lieser E; Köhl J; Chiaramonte MG
    J Immunol; 2005 Aug; 175(3):1894-902. PubMed ID: 16034133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Mechanisms in Pulmonary Fibrosis.
    Kolahian S; Fernandez IE; Eickelberg O; Hartl D
    Am J Respir Cell Mol Biol; 2016 Sep; 55(3):309-22. PubMed ID: 27149613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling.
    Herro R; Miki H; Sethi GS; Mills D; Mehta AK; Nguyen XX; Feghali-Bostwick C; Miller M; Broide DH; Soloff R; Croft M
    J Immunol; 2020 Nov; 205(9):2414-2422. PubMed ID: 32958689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases.
    Zhang Y; Tang J; Tian Z; van Velkinburgh JC; Song J; Wu Y; Ni B
    Int Rev Immunol; 2016 Sep; 35(5):399-414. PubMed ID: 26222510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activation of a T helper 2-driven innate immune response in lung fibrosis induced by multi-walled carbon nanotubes.
    Dong J; Ma Q
    Arch Toxicol; 2016 Sep; 90(9):2231-2248. PubMed ID: 27106021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and immunity in IPF pathogenesis and treatment.
    Heukels P; Moor CC; von der Thüsen JH; Wijsenbeek MS; Kool M
    Respir Med; 2019 Feb; 147():79-91. PubMed ID: 30704705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chronic lung injury and pulmonary fibrosis in mice following acute exposure to nitrogen mustard.
    Solopov P; Marinova M; Dimitropoulou C; Colunga Biancatelli RML; Catravas JD
    Inhal Toxicol; 2020 Mar; 32(4):141-154. PubMed ID: 32362214
    [No Abstract]   [Full Text] [Related]  

  • 11. Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis.
    Rydell-Törmänen K; Andréasson K; Hesselstrand R; Risteli J; Heinegård D; Saxne T; Westergren-Thorsson G
    Lab Invest; 2012 Jun; 92(6):917-25. PubMed ID: 22469699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms in fibrotic interstitial lung disease.
    Kamiya M; Carter H; Espindola MS; Doyle TJ; Lee JS; Merriam LT; Zhang F; Kawano-Dourado L; Sparks JA; Hogaboam CM; Moore BB; Oldham WM; Kim EY
    Cell; 2024 Jul; 187(14):3506-3530. PubMed ID: 38996486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice.
    Re SL; Giordano G; Yakoub Y; Devosse R; Uwambayinema F; Couillin I; Ryffel B; Marbaix E; Lison D; Huaux F
    PLoS One; 2014; 9(7):e99383. PubMed ID: 25050810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Nakano T
    Clin Exp Immunol; 2010 Dec; 162(3):560-7. PubMed ID: 20846163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunology of fibrosis: innate and adaptive responses.
    Wick G; Backovic A; Rabensteiner E; Plank N; Schwentner C; Sgonc R
    Trends Immunol; 2010 Mar; 31(3):110-9. PubMed ID: 20106721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents.
    Dong J; Yu X; Porter DW; Battelli LA; Kashon ML; Ma Q
    Arch Toxicol; 2016 Feb; 90(2):385-402. PubMed ID: 26345256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
    Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
    Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways.
    Xiong Y; Cui X; Zhou Y; Chai G; Jiang X; Ge G; Wang Y; Sun H; Che H; Nie Y; Zhao P
    Int Immunopharmacol; 2021 Sep; 98():107780. PubMed ID: 34118645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.